4//SEC Filing
GLENN JOHN 4
Accession 0001415889-24-029268
CIK 0001325618other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:00 PM ET
Size
8.2 KB
Accession
0001415889-24-029268
Insider Transaction Report
Form 4
IRADIMED CORPIRMD
GLENN JOHN
CHIEF FINANCIAL OFFICER
Transactions
- Award
Restricted Stock Units
2024-12-11+5,436→ 40,508 total→ Common Stock (5,436 underlying) - Award
Performance-based Restricted Stock Units
2024-12-11+5,435→ 23,119 total→ Common Stock (5,435 underlying)
Footnotes (3)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.
- [F3]The reporting person received performance-based restricted stock units ("PRSUs") under Iradimed Corporation's 2023 Equity Incentive Plan. PRSUs convert into common stock on a one-for-one basis. The PRSUs vest over a three-year performance period from December 12, 2024 through December 11, 2027 on the Company's total stockholder return compared to the NASDAQ US Small Cap Medical Equipment index.
Documents
Issuer
IRADIMED CORP
CIK 0001325618
Entity typeother
Related Parties
1- filerCIK 0001253497
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 4:00 PM ET
- Size
- 8.2 KB